| 000 | 01026 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515095210.0 | ||
| 264 | 0 | _c20080225 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuca, Kamil | |
| 245 | 0 | 0 |
_aStructural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2007 |
||
| 300 |
_a3445-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAcetylcholinesterase _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCholinesterase Reactivators _xchemistry |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xadverse effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aJun, Daniel | |
| 700 | 1 | _aBajgar, Jiri | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 13 _gno. 33 _gp. 3445-52 |
|
| 999 |
_c17560102 _d17560102 |
||